Related Experiment Video
Updated: Aug 9, 2026

Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with
P Nørgaard1, L Damstrup, K Rygaard
1Institute of Pathological Anatomy, University of Copenhagen, Denmark.
Abstract:
Nine human small-cell lung cancer cell lines were treated with transforming growth factor beta 1 (TGF-beta 1). Seven of the cell lines expressed receptors for transforming growth factor beta (TGF-beta-r) in different combinations between the three human subtypes I, II and III, and two were receptor negative. Growth suppression was induced by TGF-beta 1 exclusively in the five cell lines expressing the type II receptor. For the first time growth suppression by TGF-beta 1 of a cell line expressing the type II receptor without coexpression of the type I receptor is reported. No effect on growth was observed in two cell lines expressing only type III receptor and in TGF-beta-r negative cell lines. In two cell lines expressing all three receptor types, growth suppression was accompanied by morphological changes. To evaluate the possible involvement of the retinoblastoma protein (pRb) in mediating the growth-suppressive effect of TGF-beta 1, the expression of functional pRb, as characterised by nuclear localisation, was examined by immunocytochemistry. Nuclear association of pRb was only seen in two of the five TGF-beta 1-responsive cell lines. These results indicate that in SCLC pRb is not required for mediation of TGF-beta 1-induced growth suppression.
Insights
Transforming growth factor beta 1 (TGF-beta 1) suppressed small-cell lung cancer (SCLC) cell growth only in cell lines expressing the type II TGF-beta receptor. Retinoblastoma protein (pRb) was not required for this TGF-beta 1-induced growth suppression in SCLC.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Small-cell lung cancer (SCLC) is an aggressive malignancy with limited treatment options.
- Transforming growth factor beta 1 (TGF-beta 1) is a cytokine with complex roles in cancer, including growth inhibition.
- The role of TGF-beta 1 signaling and its receptors in SCLC remains incompletely understood.
Purpose of the Study:
- To investigate the effect of TGF-beta 1 on the growth of human SCLC cell lines.
- To determine the role of specific TGF-beta receptor (TGF-beta-r) subtypes in mediating TGF-beta 1's effects.
- To explore the involvement of the retinoblastoma protein (pRb) in TGF-beta 1-induced growth suppression in SCLC.
Main Methods:
- Treatment of nine human SCLC cell lines with TGF-beta 1.
- Analysis of TGF-beta-r subtype expression (I, II, III) using various combinations.
- Assessment of cell growth suppression and morphological changes.
- Immunocytochemical examination of retinoblastoma protein (pRb) nuclear localization.
Main Results:
- TGF-beta 1 induced growth suppression exclusively in five cell lines expressing the type II TGF-beta-r.
- Growth suppression was observed in a cell line expressing only type II TGF-beta-r, without type I coexpression.
- No growth effects were seen in receptor-negative cell lines or those expressing only type III TGF-beta-r.
- Nuclear localization of pRb was observed in only two of the five responsive cell lines.
Conclusions:
- The type II TGF-beta receptor is critical for mediating TGF-beta 1-induced growth suppression in SCLC.
- TGF-beta 1 can inhibit SCLC cell growth independently of type I TGF-beta receptor coexpression.
- Functional retinoblastoma protein (pRb) is not essential for TGF-beta 1-mediated growth suppression in SCLC.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
TGF - β Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

